secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vincerx Pharma, Inc. (—)
CIK:        0001796129
Form:       8-K
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0001193125-23-236156
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vincerx Pharma receives Nasdaq bid price deficiency notice
----------------------------------------------------------

- Closing bid price below $1.00 for 30 consecutive business days triggers Nasdaq notice.
- Company has 180 calendar days to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, Company may be eligible for an additional 180-day compliance period.
- Reverse stock split is among options being considered to remedy the deficiency.
- Failure to regain compliance could result in delisting from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796129/000119312523236156/0001193125-23-236156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796129/000119312523236156/d521234d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-236156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer